Cementos Pacasmayo SAA ADR

Yahoo Finance • 16 days ago

How The Cementos Pacasmayo (BVL:CPACASC1) Story Is Shifting Around Holcim Control And Tender Price

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. The latest update on Cementos PacasmayoA keeps the fair value estimate steady at PEN6.85, signaling no change in the p... Full story

Yahoo Finance • 4 months ago

Key deals this week: Trump Media & Technology, Howard Hughes, BioMarin Pharmaceutical and more

[Documents about mergers and acquisitions m&a with a pen.] designer491 Here's a list of key deals reported across sectors this week: * BioMarin Pharmaceutical (BMRN [https://seekingalpha.com/symbol/BMRN]) has agreed to acquire [https:/... Full story

Yahoo Finance • 6 months ago

Cementos Pacasmayo S.A.A. reports Q3 results

* Cementos Pacasmayo S.A.A. press release [https://seekingalpha.com/pr/20283497-cementos-pacasmayo-s-a-a-announces-consolidated-results-for-third-quarter-2025] (NYSE:CPAC [https://seekingalpha.com/symbol/CPAC]): Q3 sales volume of cement... Full story

Yahoo Finance • 9 months ago

Cementos Pacasmayo ADR earnings matched, revenue topped estimates

Investing.com - Cementos Pacasmayo ADR (NYSE: CPAC) reported second quarter EPS of $0.021, in line with the analyst estimate of $0.021. Revenue for the quarter came in at $135.89M versus the consensus estimate of $123.64M. Cementos Pacasm... Full story

Yahoo Finance • 10 months ago

Validea Peter Lynch Strategy Daily Upgrade Report - 6/10/2025

The following are today's upgrades for Validea's P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relative to earnings growth that also possess strong ba... Full story